Blythedale Children's Hospital

Blythedale Children's Hospital

Blythedale Children's Hospital opened in 1891 as a convalescent home for children in lower Manhattan, later relocating to its Valhalla campus in Westchester County. It now operates as New York State's only specialty children's hospital focused entirely on long-term, rehabilitative, and complex medical care. President and CEO Nathaniel Beers, MD, and EVP and CFO John Canning, MPA, oversee operations alongside a volunteer board of trustees that directs the hospital's endowment strategy through its investment committee. The investment committee, chaired by Perry C. Hoffmeister of Colter Lewis Investment Partners, runs a venture capital-heavy mandate typical of mid-sized endowments seeking growth-oriented returns. The committee benefits from direct healthcare operating expertise through trustee Asif Zaman, a partner and head of healthcare services at PPC Enterprises, a private equity firm specializing in corporate carve-outs and complex transactions in the healthcare sector. The fund's strategy spans general venture capital commitments. While specific portfolio holdings are not publicly disclosed, the board's composition and the hospital's research partnerships with entities like the Burke Neurological Institute suggest sourcing channels rooted in pediatric healthcare innovation and related fields. The endowment operates alongside other real assets held for charitable purposes, including the hospital's 95 Bradhurst Avenue campus and the Steven and Alexandra Cohen Pediatric Long Term Care Pavilion. External philanthropic support flows through partnerships like the BTIG Charity Day and contributions to the hospital's Wish List Fund, managed by entities such as Colbeck Capital Management. The hospital also holds a beneficial interest in trust and dedicated endowment funds in Valhalla, New York. Blythedale maintains industry ties through membership in the Healthcare Association of New York State (HANYS). Blythedale's structural differentiator lies in an endowment governed by a board that blends investment management professionals with direct healthcare operating and deal-making experience. The presence of a dedicated private equity healthcare investor as a trustee creates an uncommon adjacency between the hospital's clinical mission and its capital allocation. This governance model allows the committee to evaluate venture opportunities with both fiduciary and domain-specific lenses, a configuration rarely found in community hospital endowments of comparable size.